Back to articles

Stopping PPIs in the wrong patients


Results of a survey of almost 500 physicians showed that proton pump inhibitors (PPIs) are stopped more frequently in patients at high risk for upper gastrointestinal bleeding compared with patients who are taking PPIs for well-controlled gastroesophageal reflux disease (GERD), indicating that more education of providers is needed on proper use and discontinuation of PPIs.


Kurlander JE, et al. The right idea for the wrong patient: Results of a national survey on stopping PPIs. Clin Gastroenterol Hepatol. 2017;[Epub ahead of print].

Farrell B, et al. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354–64.